You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Weight loss drug maker sinks 25% after new safety data spooks investors ⊕

found 2026 › Jun › 08 (Mon) @ 09:50 UTC

While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.